These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 2137611)

  • 1. Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant.
    Ventura AM; Arens MQ; Srinivasan A; Chinnadurai G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1310-4. PubMed ID: 2137611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.
    Kliewer S; Garcia J; Pearson L; Soultanakis E; Dasgupta A; Gaynor R
    J Virol; 1989 Nov; 63(11):4616-25. PubMed ID: 2529378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein.
    Rice AP; Mathews MB
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4200-4. PubMed ID: 2967970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.
    Negrini M; Rimessi P; Sabbioni S; Caputo A; Balboni PG; Gualandri R; Manservigi R; Grossi MP; Barbanti-Brodano G
    Biotechniques; 1991 Mar; 10(3):344-53. PubMed ID: 1829615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
    Tsang SX; Morris GF; Lu M; Morris CB
    Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes.
    Yoshida K; Venkatesh L; Kuppuswamy M; Chinnadurai G
    Genes Dev; 1987 Sep; 1(7):645-58. PubMed ID: 2962899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the adenovirus and BK virus late promoters: effects of the BK virus enhancer and trans-acting viral early proteins.
    Grinnell BW; Berg DT; Walls J
    Mol Cell Biol; 1986 Nov; 6(11):3596-605. PubMed ID: 3025602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA octamer element can confer E1A trans-activation, and adenovirus infection results in a stimulation of the DNA-binding activity of OTF-1/NFIII factor.
    Chellappan SP; Nevins JR
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5878-82. PubMed ID: 2143023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1a proteins repress expression from polyomavirus early and late promoters.
    Velcich A; Kern FG; Basilico C; Ziff EB
    Mol Cell Biol; 1986 Nov; 6(11):4019-25. PubMed ID: 3025625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of cellular differentiation determines the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer function.
    Herbst RS; Pelletier M; Boczko EM; Babiss LE
    J Virol; 1990 Jan; 64(1):161-72. PubMed ID: 2136708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene.
    Olive DM; al-Mulla W; Simsek M; Zarban S; al-Nakib W
    Arch Virol; 1990; 112(1-2):67-80. PubMed ID: 2142416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adenovirus oncogenes in down-regulation of major histocompatibility class I gene expression.
    Sharma E; Hollett T; Zajdel ME; Blair GE
    Biochem Soc Trans; 1991 Apr; 19(2):84S. PubMed ID: 1832401
    [No Abstract]   [Full Text] [Related]  

  • 13. NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.
    Spergel JM; Hsu W; Akira S; Thimmappaya B; Kishimoto T; Chen-Kiang S
    J Virol; 1992 Feb; 66(2):1021-30. PubMed ID: 1309887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
    Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional diversity of E1A gene autoregulation among human adenoviruses.
    Cogan JD; Jones SN; Hall RK; Tibbetts C
    J Virol; 1992 Jun; 66(6):3833-45. PubMed ID: 1533882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency viral long terminal repeat is functional and can be trans-activated in Escherichia coli.
    Kashanchi F; Wood C
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2157-61. PubMed ID: 2648391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct DNA targets for trans-activation by HTLV-1 tax and adenovirus E1A.
    Nicholas J; Nevins JR
    Virology; 1991 May; 182(1):156-67. PubMed ID: 1827222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of insertion mutants in E1A of adenovirus type 5.
    Bautista DS; Hitt M; McGrory J; Graham FL
    Virology; 1991 Jun; 182(2):578-96. PubMed ID: 1827228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.